tiprankstipranks
Advertisement
Advertisement

GLSI Stock Latest News

Greenwich LifeSciences says Form 10-K ‘still being audited’
The FlyGreenwich LifeSciences says Form 10-K ‘still being audited’
10d ago
GLSI
Greenwich LifeSciences receives noncompliance notification from Nasdaq
PremiumThe Fly
Greenwich LifeSciences receives noncompliance notification from Nasdaq
17d ago
GLSI
Greenwich LifeSciences presents Flamingo-01 Phase 3 results from AACR 2026
PremiumThe Fly
Greenwich LifeSciences presents Flamingo-01 Phase 3 results from AACR 2026
20d ago
GLSI
Greenwich LifeSciences reports cash balance of $10.5M as of March 31
PremiumThe Fly
Greenwich LifeSciences reports cash balance of $10.5M as of March 31
26d ago
GLSI
Greenwich LifeSciences updates on new patent claims based on FLAMINGO-01
PremiumThe Fly
Greenwich LifeSciences updates on new patent claims based on FLAMINGO-01
1M ago
GLSI
Greenwich LifeSciences Delays Annual SEC Filing
PremiumCompany AnnouncementsGreenwich LifeSciences Delays Annual SEC Filing
1M ago
GLSI
Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial
Premium
The Fly
Greenwich LifeSciences adds City of Hope to FLAMINGO-01 trial
2M ago
GLSI
Greenwich LifeSciences provides update on presentations at AACR Meeting 2026
Premium
The Fly
Greenwich LifeSciences provides update on presentations at AACR Meeting 2026
2M ago
GLSI
Greenwich LifeSciences’ GLSI-100 reduces recurrence rate in Phase 3 trial
PremiumThe Fly
Greenwich LifeSciences’ GLSI-100 reduces recurrence rate in Phase 3 trial
2M ago
GLSI
Greenwich announces use of commercially manufactured GP2 in FLAMINGO-01
PremiumThe Fly
Greenwich announces use of commercially manufactured GP2 in FLAMINGO-01
2M ago
GLSI
Greenwich LifeSciences provides update on screen rate in FLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences provides update on screen rate in FLAMINGO-01 trial
2M ago
GLSI
Greenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target
PremiumRatings
Greenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target
3M ago
GLSI
Greenwich LifeSciences provides financial update on FLAMINGO-01 Phase 3 trial
PremiumThe FlyGreenwich LifeSciences provides financial update on FLAMINGO-01 Phase 3 trial
3M ago
GLSI
Greenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
Premium
The Fly
Greenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
4M ago
GLSI
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
Premium
Ratings
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
4M ago
GLSI
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
PremiumThe Fly
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
4M ago
GLSI
Greenwich LifeSciences extends lock-up of directors, officers to September 30
PremiumThe Fly
Greenwich LifeSciences extends lock-up of directors, officers to September 30
4M ago
GLSI
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters
PremiumThe Fly
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters
5M ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences provides update on FLAMINGO-01 trial
5M ago
GLSI
Greenwich LifeSciences Stockholders Reelect Board and Auditor
PremiumCompany AnnouncementsGreenwich LifeSciences Stockholders Reelect Board and Auditor
5M ago
8K
GLSI
Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm
Premium
The Fly
Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm
5M ago
GLSI
Greenwich LifeSciences: Enrollment complete in open label arm oFLAMINGO-01 trial
Premium
The Fly
Greenwich LifeSciences: Enrollment complete in open label arm oFLAMINGO-01 trial
5M ago
GLSI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >